<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">VES</journal-id>
<journal-id journal-id-type="hwp">spves</journal-id>
<journal-id journal-id-type="nlm-ta">Vasc Endovascular Surg</journal-id>
<journal-title>Vascular and Endovascular Surgery</journal-title>
<issn pub-type="ppub">1538-5744</issn>
<issn pub-type="epub">1938-9116</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1538574412474497</article-id>
<article-id pub-id-type="publisher-id">10.1177_1538574412474497</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Clinical Research Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Impact of Endograft Surveillance on a Vascular Imaging Service</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Karthikesalingam</surname>
<given-names>Alan</given-names>
</name>
<degrees>MSc, MA, MRCS, MBBChir</degrees>
<xref ref-type="aff" rid="aff1-1538574412474497">1</xref>
<xref ref-type="corresp" rid="corresp1-1538574412474497"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Young</surname>
<given-names>Mark</given-names>
</name>
<degrees>MSc</degrees>
<xref ref-type="aff" rid="aff2-1538574412474497">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Powell</surname>
<given-names>Sophie A.</given-names>
</name>
<degrees>BSc</degrees>
<xref ref-type="aff" rid="aff2-1538574412474497">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Morshedian</surname>
<given-names>Golnaz</given-names>
</name>
<degrees>BSc</degrees>
<xref ref-type="aff" rid="aff2-1538574412474497">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ramachandran</surname>
<given-names>Veni</given-names>
</name>
<degrees>BSc</degrees>
<xref ref-type="aff" rid="aff2-1538574412474497">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>D’Abate</surname>
<given-names>Fabrizio</given-names>
</name>
<degrees>MSc</degrees>
<xref ref-type="aff" rid="aff2-1538574412474497">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Thompson</surname>
<given-names>Matthew M.</given-names>
</name>
<degrees>MD, MA, FRCS, MBBS</degrees>
<xref ref-type="aff" rid="aff1-1538574412474497">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Holt</surname>
<given-names>Peter J. E.</given-names>
</name>
<degrees>PhD, BSc, FRCS</degrees>
<xref ref-type="aff" rid="aff1-1538574412474497">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1538574412474497">
<label>1</label>Department of Outcomes Research, St George’s Vascular Institute, London, United Kingdom</aff>
<aff id="aff2-1538574412474497">
<label>2</label>Vascular Laboratory, St George’s Vascular Institute, London, United Kingdom</aff>
<author-notes>
<corresp id="corresp1-1538574412474497">Alan Karthikesalingam, St George’s Vascular Institute, Room 4.007, St George’s Healthcare NHS Trust, Blackshaw Road, London SW17 0QT, United Kingdom. Email: <email>alankarthi@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>2</month>
<year>2013</year>
</pub-date>
<volume>47</volume>
<issue>2</issue>
<fpage>92</fpage>
<lpage>96</lpage>
<permissions>
<copyright-statement>© The Author(s) 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<sec><title>Background:</title>
<p>Surveillance is considered mandatory after endovascular repair (EVR), but its impact on imaging services remains unreported. This study reports the effect of EVR surveillance on imaging resources.</p>
</sec>
<sec><title>Methods:</title>
<p>A single-center’s duplex database was interrogated from January 1, 2004 to January 1, 2012. All examinations requested by a vascular surgeon were reported, including preoperative abdominal aortic aneurysms, surveillance after EVR, lower limb arterial and venous duplex, and arteriovenous fistulae.</p>
</sec>
<sec><title>Results:</title>
<p>A total of 24 309 patients underwent duplex. The EVR surveillance increased from 192 scans in 2004 to 1325 scans in 2011, 9.5% (192 of 2030) and 34.4% (1325 of 3850) of each year’s examinations. By 2011, EVR surveillance was the most common indication for duplex.</p>
</sec>
<sec><title>Conclusion:</title>
<p>Lifelong EVR surveillance creates a rapidly increasing workload for imaging services. Further research should aim to reduce the burden of EVR surveillance. Targeting surveillance to the minority of patients at greatest risk of endograft failure might optimize the usage of imaging resources.</p>
</sec>
</abstract>
<kwd-group>
<kwd>duplex</kwd>
<kwd>EVAR</kwd>
<kwd>workload</kwd>
<kwd>surveillance</kwd>
<kwd>resource utilization</kwd>
<kwd>endovascular aneurysm repair</kwd>
<kwd>imaging</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1538574412474497">
<title>Introduction</title>
<p>Endovascular repair (EVR) permits the treatment of abdominal aortic aneurysms (AAAs) with low perioperative mortality,<sup>
<xref ref-type="bibr" rid="bibr1-1538574412474497">1</xref>
<xref ref-type="bibr" rid="bibr2-1538574412474497"/>–<xref ref-type="bibr" rid="bibr3-1538574412474497">3</xref>
</sup> is preferred by patients,<sup>
<xref ref-type="bibr" rid="bibr4-1538574412474497">4</xref>
</sup> and is the most common method of AAA repair in the United Kingdom.<sup>
<xref ref-type="bibr" rid="bibr5-1538574412474497">5</xref>
</sup> Endograft complications develop in 20% of patients within 4 years of EVR<sup>
<xref ref-type="bibr" rid="bibr2-1538574412474497">2</xref>
</sup> and require intervention to prevent aneurysm-related mortality. Lifelong surveillance is therefore considered mandatory.<sup>
<xref ref-type="bibr" rid="bibr6-1538574412474497">6</xref>
</sup> However, surveillance protocols vary widely across national practice<sup>
<xref ref-type="bibr" rid="bibr7-1538574412474497">7</xref>
</sup> and expose patients to radiation exposure<sup>
<xref ref-type="bibr" rid="bibr8-1538574412474497">8</xref>
</sup> and contrast nephropathy,<sup>
<xref ref-type="bibr" rid="bibr9-1538574412474497">9</xref>
</sup> while failing to identify the majority of complications requiring treatment.<sup>
<xref ref-type="bibr" rid="bibr10-1538574412474497">10</xref>
</sup>
</p>
<p>Modifications to postoperative surveillance can alter the long-term cost-effectiveness of EVR. A model derived using EVAR-1 trial data suggested that EVR might not be cost-effective if followed with annual computed tomography (CT),<sup>
<xref ref-type="bibr" rid="bibr11-1538574412474497">11</xref>,<xref ref-type="bibr" rid="bibr12-1538574412474497">12</xref>
</sup> while contemporary recommendations have acknowledged that replacing CT with ultrasound surveillance improves cost-effectiveness.<sup>
<xref ref-type="bibr" rid="bibr11-1538574412474497">11</xref>
</sup> National recommendations have concluded that further research is needed to improve the cost-effectiveness and clinical-effectiveness of surveillance after EVR.<sup>
<xref ref-type="bibr" rid="bibr11-1538574412474497">11</xref>,<xref ref-type="bibr" rid="bibr12-1538574412474497">12</xref>
</sup> In addition to the clinical and economic impact on the wider health care system, a policy of routine lifelong surveillance after EVR might exert a cumulative effect on the workload of local imaging services. This aim of this study was to define annual trends in activity at a specialist vascular laboratory, and investigate the changing workload that was attributable to EVR surveillance.</p>
</sec>
<sec id="section2-1538574412474497" sec-type="methods">
<title>Methods</title>
<p>A single center’s prospectively maintained database was interrogated, which included all patients undergoing duplex ultrasound in a specialist vascular laboratory over an 8-year period from January 1, 2004 to January 1, 2012. The regional vascular unit offers complex vascular and endovascular surgery to a catchment area of 2.2 million, with the introduction of an AAA screening program in June 2009.<sup>
<xref ref-type="bibr" rid="bibr13-1538574412474497">13</xref>
</sup> Patients are referred for discussion from 4 peripheral “spoke” hospitals, and all arterial surgery occurs at the central “hub.” Surveillance after EVR is performed centrally, although vein graft surveillance after lower extremity arterial bypass (LEAB) may be performed locally in spoke hospitals. Venous duplex and arteriovenous fistula (AVF) surveillance are provided both locally and centrally.</p>
<sec id="section3-1538574412474497">
<title>Inclusion Criteria</title>
<p>All duplex ultrasound examinations requested by a vascular surgeon were included in the study, comprising preoperative AAA, post-EVR surveillance, lower limb arterial, LEAB surveillance, superficial or deep venous, and AVF scans. All other examinations were grouped for analysis, including upper limb arterial or venous scans, exercise tests for entrapment syndromes or claudication, and conduit mapping prior to fistula formation or arterial bypass.</p>
</sec>
<sec id="section4-1538574412474497">
<title>Exclusion Criteria</title>
<p>Duplex ultrasounds not requested by vascular surgeons were excluded. In local practice, this referred exclusively to carotid ultrasounds, which were requested directly by neurologists within the framework of a hyperacute stroke unit, and transcranial Doppler ultrasounds requested by pediatricians for sickle cell disease.</p>
</sec>
<sec id="section5-1538574412474497">
<title>Standard Imaging Protocols</title>
<sec id="section6-1538574412474497">
<title>Surveillance After EVR</title>
<p>All patients underwent biplanar angiography at the completion of EVR and were enrolled in the institution’s surveillance program. Duplex ultrasound was performed prior to discharge from hospital, at 6 weeks, 3 months, 6 months, 9 months, 12 months, 18 months, and annually thereafter, accompanied by plain abdominal radiograph prior to discharge and annually thereafter. In all cases where surveillance detected a clinically significant complication, or when patients presented symptomatically between surveillance scans, a contrast-enhanced CT was performed to direct reintervention. All patients underwent clinical evaluation at 6 weeks and 12 months after the index procedure and annually thereafter. An aggressive reintervention policy was followed which has previously been described,<sup><xref ref-type="bibr" rid="bibr10-1538574412474497">10</xref></sup> performed for type 1 endoleak, type 2 endoleak with sac expansion &gt;5 mm on CT, type 3 endoleak, limb kinking or stenosis, and graft migration &gt;5 mm, in patients presenting symptomatically or asymptomatically through the surveillance program. The minimal criterion for clinical referral for further investigation was defined as a 2.5-fold increase in peak systolic velocity (PSV) on duplex ultrasound, with intervention mandated for hemodynamically significant 3-fold increase in PSV.<sup><xref ref-type="bibr" rid="bibr14-1538574412474497">14</xref></sup>
</p>
</sec>
<sec id="section7-1538574412474497">
<title>Surveillance After LEAB</title>
<p>All patients underwent antegrade angiography at the completion of LEAB and were enrolled in the institution’s surveillance program if venous conduit was used. Surveillance comprised graft duplex prior to discharge from hospital, at 6 weeks, 3 months, 6 months, 12 months, 18 months, and 24 months; patients were discharged at this stage if no complications were reported. Grafts were deemed at risk of failure in the presence of an absolute minimum PSV lower than 40 cm/s at any point in the graft indicating a low flow state or a 2.5-fold increase in PSV indicating potential stenosis. If any intervention was performed, patients were reentered into the surveillance protocol from its beginning.</p>
</sec>
<sec id="section8-1538574412474497">
<title>Preoperative Aneurysmal Disease</title>
<p>The AAA measurements were recorded from outer wall to outer wall. Male patients with small AAA under surveillance underwent duplex ultrasound at intervals of 12, 6, and 3 months for AAA of diameters 30 to 40, 40 to 50, and 50 to 55 mm, respectively. Female patients underwent duplex ultrasound at intervals of 12, 6, and 3 months for AAA of diameter 30 to 35, 35 to 40, and 40 to 45 mm, respectively. Senior clinical review, including CT scan, was triggered for AAA greater than 50 mm in male patients or 40 mm in female patients, or by rapid expansion of 5 mm in 6 months.</p>
<p>Iliac aneurysms underwent imaging at 6-month intervals if the diameter was 20 to 30 mm, with clinical review for those greater than 30 mm. Patients with femoral aneurysms underwent duplex ultrasound annually for diameters of 15 to 25 mm, with clinical review for those greater than 25 mm. Popliteal aneurysms underwent duplex ultrasound at intervals of 12 and 6 months for diameters of 15 to 20 mm or 20 to 25 mm, respectively, with clinical review for those greater than 25 mm.</p>
</sec>
</sec>
</sec>
<sec id="section9-1538574412474497">
<title>Results</title>
<p>Between January 1, 2004 and January 1, 2012, 24 309 episodes of duplex ultrasound imaging were requested by a vascular surgeon. The total annual workload increased considerably from 2030 scans performed in 2004 to 3850 scans performed in 2011. Over the total study period, 26.8% (6516 of 24 309) of the scans were performed for lower limb arterial examination or bypass graft surveillance, 26.6% (6473 of 24 309) for EVR surveillance, 22.6% (5499 of 24 309) for superficial and deep venous duplex, 8.4% (2034 of 24 309) for preoperative AAA, 3.8% (931 of 24 309) for AVF surveillance, and 11.7% (2856 of 24 309) for other indications.</p>
<p>The EVR surveillance accounted for 9.5% (192 of 2030) of the scans performed in 2004 and increased to 34.4% (1325 of 3850) of the annual workload in 2011, representing the most common indication for duplex ultrasound by the end of the study and increasing 7-fold in absolute terms (<xref ref-type="fig" rid="fig1-1538574412474497">Figure 1</xref>). Over the same time period, the proportion of annual workload accounted for by other examinations changed from 7.1% (145 of 2030) to 10.8% (416 of 3850) for small AAA surveillance, from 33.1% (671 of 2030) to 30.5% (1173 of 3850) for lower limb arterial examination or bypass graft surveillance, and from 0% to 5.3% (205 of 3850) for AVF surveillance.</p>
<fig id="fig1-1538574412474497" position="float">
<label>Figure 1.</label>
<caption>
<p>Annual workload of a specialist vascular laboratory from January 1, 2004 to January 1, 2012.</p>
</caption>
<graphic xlink:href="10.1177_1538574412474497-fig1.tif"/>
</fig>
<p>Venous duplex decreased from 30.7% of annual workload in 2004 (623 of 2030) to 12.4% in 2011 (478 of 3850). Scans performed for upper limb arterial or venous assessment, exercise tests for entrapment syndromes or claudication, and conduit mapping prior to surgery decreased from 19.7% of annual workload in 2004 (399 of 2030) to 6.6% in 2011 (253 of 3850).</p>
</sec>
<sec id="section10-1538574412474497">
<title>Discussion</title>
<p>Over an 8-year study period, the overall workload of a regional center’s vascular duplex laboratory increased steadily. The EVR surveillance in particular demonstrated a considerably greater escalation in activity, and was the most common indication for specialist imaging by the end of the study period (<xref ref-type="fig" rid="fig1-1538574412474497">Figure 1</xref>).</p>
<p>Surveillance after EVR remains heterogeneous. In the United Kingdom one-third of the centers use CT, one-third use ultrasound, and one-third use a combination of both the techniques as the primary imaging modality.<sup>
<xref ref-type="bibr" rid="bibr15-1538574412474497">15</xref>
</sup> The intensity of postoperative imaging varies widely, and while 27% of UK centers advocate cessation of surveillance in uncomplicated patients after 5 years, 73% of centers report lifelong imaging and do not have a defined end point for surveillance.<sup>
<xref ref-type="bibr" rid="bibr15-1538574412474497">15</xref>
</sup> Although all-cause mortality is appreciable in the decade after EVR,<sup>
<xref ref-type="bibr" rid="bibr2-1538574412474497">2</xref>
</sup> the enrolment of all patients with EVR in lifelong surveillance creates a considerable and cumulative workload for imaging facilities.</p>
<p>Many centers initially adopted surveillance protocols from early scientific trials, which used CT as the gold standard of surveillance.<sup>
<xref ref-type="bibr" rid="bibr16-1538574412474497">16</xref>
</sup> However, excessive reliance on CT is expensive<sup>
<xref ref-type="bibr" rid="bibr17-1538574412474497">17</xref>
</sup> and necessitates the repeated exposure of asymptomatic patients to nephrotoxic intravenous contrast<sup>
<xref ref-type="bibr" rid="bibr9-1538574412474497">9</xref>
</sup> and ionizing radiation.<sup>
<xref ref-type="bibr" rid="bibr8-1538574412474497">8</xref>
</sup> Increasing the proportional use of nonnephrotoxic imaging has been advocated as an alternative strategy to reduce surveillance-related morbidity<sup>
<xref ref-type="bibr" rid="bibr18-1538574412474497">18</xref>
</sup> and improve cost-effectiveness.<sup>
<xref ref-type="bibr" rid="bibr19-1538574412474497">19</xref>
</sup> Duplex ultrasound offers comparable accuracy compared to CT for the detection of “high-risk” (type 1 and type 3) endoleak requiring intervention<sup>
<xref ref-type="bibr" rid="bibr20-1538574412474497">20</xref>
</sup> and has been shown to enable 29% reduction in surveillance costs compared to CT, without compromising safety.<sup>
<xref ref-type="bibr" rid="bibr19-1538574412474497">19</xref>
</sup>
</p>
<p>The risk of major endograft complications after EVR is not homogeneous<sup>
<xref ref-type="bibr" rid="bibr10-1538574412474497">10</xref>
</sup>; a minority of patients are at greater risk than others and constitute a high-risk group in whom surveillance is of greater significance. Evidence suggests that hostile aneurysm morphology is prognostic of endograft complications<sup>
<xref ref-type="bibr" rid="bibr10-1538574412474497">10</xref>,<xref ref-type="bibr" rid="bibr21-1538574412474497">21</xref>,<xref ref-type="bibr" rid="bibr22-1538574412474497">22</xref>
</sup> and there is recurring evidence that increasing preoperative aneurysm<sup>
<xref ref-type="bibr" rid="bibr23-1538574412474497">23</xref>
<xref ref-type="bibr" rid="bibr24-1538574412474497"/>
<xref ref-type="bibr" rid="bibr25-1538574412474497"/>–<xref ref-type="bibr" rid="bibr26-1538574412474497">26</xref>
</sup> and common iliac diameter<sup>
<xref ref-type="bibr" rid="bibr24-1538574412474497">24</xref>,<xref ref-type="bibr" rid="bibr27-1538574412474497">27</xref>,<xref ref-type="bibr" rid="bibr28-1538574412474497">28</xref>
</sup> in particular are associated with a higher risk of endograft failure. The development of a preoperative morphological scoring system to predictively identify patients at high risk of aortic complications would allow intensive surveillance of the subgroup of patients at greatest risk with a reduction in surveillance in those at lowest risk. This hypothesis remains the focus of ongoing research.<sup>
<xref ref-type="bibr" rid="bibr29-1538574412474497">29</xref>,<xref ref-type="bibr" rid="bibr30-1538574412474497">30</xref>
</sup> Targeting surveillance to those at greatest risk, and reducing surveillance in those at lower risk of aortic complications after EVR, might alleviate the overall burden of lifelong EVR surveillance on imaging resources.</p>
<sec id="section11-1538574412474497">
<title>Limitations</title>
<p>This study reflects vascular practice at a single regional center with a high annual caseload of EVR and may not be applicable to lower volume endovascular practice.<sup>
<xref ref-type="bibr" rid="bibr31-1538574412474497">31</xref>
</sup> National heterogeneity in surveillance<sup>
<xref ref-type="bibr" rid="bibr15-1538574412474497">15</xref>
</sup> could confound comparisons of the resulting burden of different protocols on imaging services, which might vary locally.</p>
</sec>
</sec>
<sec id="section12-1538574412474497">
<title>Conclusion</title>
<p>A uniform strategy of lifelong surveillance for all patients undergoing EVR creates a rapidly increasing workload for specialist imaging services. The improved prediction of endograft complications is required to develop recommendations for risk-stratified surveillance after EVR. Targeting surveillance to the minority of patients at greatest risk of endograft failure and reducing surveillance in the majority of patients at low risk of aortic complications might moderate the extent to which imaging resources are utilized by EVR surveillance.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="other" id="fn1-1538574412474497">
<label>Authors’ Note</label>
<p>The views expressed in this publication are those of the authors and not necessarily those of the NIHR or NHS.</p>
</fn>
<fn fn-type="conflict" id="fn2-1538574412474497">
<label>Declaration of Conflicting Interests</label>
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn3-1538574412474497">
<label>Funding</label>
<p>The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Alan Karthikesalingam is a Doctoral Research Fellow financially supported by the National Institute for Health Research and the Circulation Foundation Surgeon Scientist Award. Peter Holt is a Clinician Scientist financially supported by the National Institute for Health Research.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1538574412474497">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Bruin</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Baas</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Buth</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Long-term outcome of open or endovascular repair of abdominal aortic aneurysm</article-title>. <source>N Engl J Med</source>. <year>2010</year>;<volume>362</volume>(<issue>20</issue>):<fpage>1881</fpage>–<lpage>1889</lpage>.</citation>
</ref>
<ref id="bibr2-1538574412474497">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greenhalgh</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Epstein</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sculpher</surname>
<given-names>MJ</given-names>
</name>
</person-group>. <article-title>Endovascular versus open repair of abdominal aortic aneurysm</article-title>. <source>N Engl J Med</source>. <year>2010</year>;<volume>362</volume>(<issue>20</issue>):<fpage>1863</fpage>–<lpage>1871</lpage>.</citation>
</ref>
<ref id="bibr3-1538574412474497">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nordon</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Karthikesalingam</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hinchliffe</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Holt</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Loftus</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>MM</given-names>
</name>
</person-group>. <article-title>Secondary interventions following endovascular aneurysm repair (EVAR) and the enduring value of graft surveillance</article-title>. <source>Eur J Vasc Endovasc Surg</source>. <year>2010</year>;<volume>39</volume>(<issue>5</issue>):<fpage>547</fpage>–<lpage>554</lpage>.</citation>
</ref>
<ref id="bibr4-1538574412474497">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winterborn</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Amin</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Lyratzopoulos</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Varty</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>WB</given-names>
</name>
</person-group>. <article-title>Preferences for endovascular (EVAR) or open surgical repair among patients with abdominal aortic aneurysms under surveillance</article-title>. <source>J Vasc Surg</source>. <year>2009</year>;<volume>49</volume>(<issue>3</issue>):<fpage>576</fpage>–<lpage>581</lpage> e3.</citation>
</ref>
<ref id="bibr5-1538574412474497">
<label>5</label>
<citation citation-type="journal">
<collab collab-type="author">NICE technology appraisal guidance 167</collab>. <article-title>Endovascular stent-grafts for the treatment of abdominal aortic aneurysms</article-title>. <source>National Institute for Health and Clinical Excellence</source>, London. <year>2009</year>.</citation>
</ref>
<ref id="bibr6-1538574412474497">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moll</surname>
<given-names>FL</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Fraedrich</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Management of abdominal aortic aneurysms clinical practice guidelines of the European society for vascular surgery</article-title>. <source>Eur J Vasc Endovasc Surg</source>. <year>2011</year>;<volume>41</volume>(<issue>suppl 1</issue>):<fpage>S1</fpage>–<lpage>S58</lpage>.</citation>
</ref>
<ref id="bibr7-1538574412474497">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karthikesalingam</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Page</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Pettengell</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Heterogeneity in surveillance after endovascular aneurysm repair in the UK</article-title>. <source>Eur J Vasc Endovasc Surg</source>. <year>2011</year>.</citation>
</ref>
<ref id="bibr8-1538574412474497">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weerakkody</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Cousins</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Goldstone</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>TY</given-names>
</name>
<name>
<surname>Gaunt</surname>
<given-names>ME</given-names>
</name>
</person-group>. <article-title>Radiation exposure during endovascular aneurysm repair</article-title>. <source>Br J Surg</source>. <year>2008</year>;<volume>95</volume>(<issue>6</issue>):<fpage>699</fpage>–<lpage>702</lpage>.</citation>
</ref>
<ref id="bibr9-1538574412474497">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walsh</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>TY</given-names>
</name>
<name>
<surname>Boyle</surname>
<given-names>JR</given-names>
</name>
</person-group>. <article-title>Renal consequences of endovascular abdominal aortic aneurysm repair</article-title>. <source>J Endovasc Ther</source> <year>2008</year>;<volume>15</volume>(<issue>1</issue>):<fpage>73</fpage>–<lpage>82</lpage>.</citation>
</ref>
<ref id="bibr10-1538574412474497">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karthikesalingam</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Holt</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Hinchliffe</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Nordon</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Loftus</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>MM</given-names>
</name>
</person-group>. <article-title>Risk of reintervention after endovascular aortic aneurysm repair</article-title>. <source>Br J Surg</source>. <year>2010</year>;<volume>97</volume>(<issue>5</issue>):<fpage>657</fpage>–<lpage>663</lpage>.</citation>
</ref>
<ref id="bibr11-1538574412474497">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Epstein</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sculpher</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Greenhalgh</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>The UK EndoVascular Aneurysm Repair (EVAR) trials: randomised trials of EVAR versus standard therapy</article-title>. <source>Health Technol Assess</source>. <year>2012</year>;<volume>16</volume>(<issue>9</issue>):<fpage>1</fpage>–<lpage>218</lpage>.</citation>
</ref>
<ref id="bibr12-1538574412474497">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chambers</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Epstein</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Endovascular stents for abdominal aortic aneurysms: a systematic review and economic model</article-title>. <source>Health Technol Assess</source>. <year>2009</year>;<volume>13</volume>(<issue>48</issue>):<fpage>1</fpage>–<lpage>189</lpage>, <fpage>215</fpage>–<lpage>318</lpage>, iii.</citation>
</ref>
<ref id="bibr13-1538574412474497">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Conway</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Malkawi</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Hinchliffe</surname>
<given-names>RJ</given-names>
</name>
<etal/>
</person-group>. <article-title>First-year results of a national abdominal aortic aneurysm screening programme in a single centre</article-title>. <source>Br J Surg</source>. <year>2012</year>;<volume>99</volume>(<issue>1</issue>):<fpage>73</fpage>–<lpage>77</lpage>.</citation>
</ref>
<ref id="bibr14-1538574412474497">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karthikesalingam</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Anandarajah</surname>
<given-names>JJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Predictive value of peak systolic velocity for the development of graft limb complications after endovascular aneurysm repair</article-title>. <source>J Endovasc Ther</source>. <year>2012</year>;<volume>19</volume>(<issue>3</issue>):<fpage>428</fpage>–<lpage>433</lpage>.</citation>
</ref>
<ref id="bibr15-1538574412474497">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karthikesalingam</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Page</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Pettengell</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Heterogeneity in surveillance after endovascular aneurysm repair in the UK</article-title>. <source>Eur J Vasc Endovasc Surg</source>. <year>2011</year>;<volume>42</volume>(<issue>5</issue>):<fpage>585</fpage>–<lpage>90</lpage>.</citation>
</ref>
<ref id="bibr16-1538574412474497">
<label>16</label>
<citation citation-type="journal">
<collab collab-type="author">EVAR Trial Participants</collab>. <article-title>Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial</article-title>. <source>The Lancet</source>. <year>2005</year>;<volume>365</volume>(<issue>9478</issue>):<fpage>2179</fpage>–<lpage>2186</lpage>.</citation>
</ref>
<ref id="bibr17-1538574412474497">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michaels</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Drury</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>SM</given-names>
</name>
</person-group>. <article-title>Cost-effectiveness of endovascular abdominal aortic aneurysm repair</article-title>. <source>Br J Surg</source>. <year>2005</year>;<volume>92</volume>(<issue>8</issue>):<fpage>960</fpage>–<lpage>967</lpage>.</citation>
</ref>
<ref id="bibr18-1538574412474497">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boyle</surname>
<given-names>JR</given-names>
</name>
</person-group>. <article-title>Long-term outcome of endovascular abdominal aortic aneurysm repair</article-title>. <source>Br J Surg</source>. <year>2009</year>;<volume>96</volume>(<issue>5</issue>):<fpage>447</fpage>–<lpage>448</lpage>.</citation>
</ref>
<ref id="bibr19-1538574412474497">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beeman</surname>
<given-names>BR</given-names>
</name>
<name>
<surname>Doctor</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Doerr</surname>
<given-names>K</given-names>
</name>
<name>
<surname>McAfee-Bennett</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dougherty</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Calligaro</surname>
<given-names>KD</given-names>
</name>
</person-group>. <article-title>Duplex ultrasound imaging alone is sufficient for midterm endovascular aneurysm repair surveillance: a cost analysis study and prospective comparison with computed tomography scan</article-title>. <source>J Vasc Surg</source>. <year>2009</year>;<volume>50</volume>(<issue>5</issue>):<fpage>1019</fpage>–<lpage>1024</lpage>.</citation>
</ref>
<ref id="bibr20-1538574412474497">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karthikesalingam</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Al-Jundi</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Duplex ultrasound, contrast-enhanced ultrasound or CT for surveillance after endovascular aneurysm repair</article-title>. <source>Br J Surg</source>. <year>2012</year>;<volume>99</volume>(<issue>11</issue>):<fpage>1514</fpage>–<lpage>1523</lpage>.</citation>
</ref>
<ref id="bibr21-1538574412474497">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schanzer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Hevelone</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Predictors of abdominal aortic aneurysm sac enlargement after endovascular repair</article-title>. <source>Circulation</source>. <year>2011</year>;<volume>123</volume>(<issue>24</issue>):<fpage>2848</fpage>–<lpage>2855</lpage>.</citation>
</ref>
<ref id="bibr22-1538574412474497">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wyss</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Dick</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Greenhalgh</surname>
<given-names>RM</given-names>
</name>
</person-group>. <article-title>The influence of thrombus, calcification, angulation, and tortuosity of attachment sites on the time to the first graft-related complication after endovascular aneurysm repair</article-title>. <source>J Vasc Surg</source>. <year>2011</year>;<volume>54</volume>(<issue>4</issue>):<fpage>965</fpage>–<lpage>971</lpage>.</citation>
</ref>
<ref id="bibr23-1538574412474497">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zarins</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Crabtree</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bloch</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Arko</surname>
<given-names>FR</given-names>
</name>
<name>
<surname>Ouriel</surname>
<given-names>K</given-names>
</name>
<name>
<surname>White</surname>
<given-names>RA</given-names>
</name>
</person-group>. <article-title>Endovascular aneurysm repair at 5 years: does aneurysm diameter predict outcome?</article-title> <source>J Vasc Surg</source>. <year>2006</year>;<volume>44</volume>(<issue>5</issue>):<fpage>920</fpage>–<lpage>929</lpage>; <comment>discussion 9-31</comment>.</citation>
</ref>
<ref id="bibr24-1538574412474497">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Greenhalgh</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>SG</given-names>
</name>
</person-group>. <article-title>Use of baseline factors to predict complications and reinterventions after endovascular repair of abdominal aortic aneurysm</article-title>. <source>Br J Surg</source>. <year>2010</year>;<volume>97</volume>(<issue>8</issue>):<fpage>1207</fpage>–<lpage>1217</lpage>.</citation>
</ref>
<ref id="bibr25-1538574412474497">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frego</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lumachi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Bianchera</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Risk factors of endoleak following endovascular repair of abdominal aortic aneurysm. A multicentric retrospective study</article-title>. <source>In Vivo</source>. <year>2007</year>;<volume>21</volume>(<issue>6</issue>):<fpage>1099</fpage>–<lpage>1102</lpage>.</citation>
</ref>
<ref id="bibr26-1538574412474497">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peppelenbosch</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Buth</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>van Marrewijk</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fransen</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Diameter of abdominal aortic aneurysm and outcome of endovascular aneurysm repair: does size matter? A report from EUROSTAR</article-title>. <source>J Vasc Surg</source>. <year>2004</year>;<volume>39</volume>(<issue>2</issue>):<fpage>288</fpage>–<lpage>297</lpage>.</citation>
</ref>
<ref id="bibr27-1538574412474497">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schanzer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Hevelone</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Predictors of abdominal aortic aneurysm sac enlargement after endovascular repair</article-title>. <source>Circulation</source>. <year>2011</year>;<volume>123</volume>(<issue>24</issue>):<fpage>2848</fpage>–<lpage>2855</lpage>.</citation>
</ref>
<ref id="bibr28-1538574412474497">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hobo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sybrandy</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Buth</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Endovascular repair of abdominal aortic aneurysms with concomitant common iliac artery aneurysm: outcome analysis of the EUROSTAR Experience</article-title>. <source>J Endovasc Ther</source>. <year>2008</year>;<volume>15</volume>(<issue>1</issue>):<fpage>12</fpage>–<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr29-1538574412474497">
<label>29</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Ghatwary</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>BO</given-names>
</name>
<name>
<surname>Karthikesalingam</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>A systematic review of protocols for the 3-dimensional morphological assessment of abdominal aortic aneurysms using computerized tomography angiography [published online December 10, 2011]</article-title>. <source>Cardiovasc Intervent Radiol</source>. <year>2011</year>.</citation>
</ref>
<ref id="bibr30-1538574412474497">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghatwary</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>BO</given-names>
</name>
<name>
<surname>Karthikesalingam</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>The St George’s Vascular Institute (SGVI) Protocol: an accurate and reproducible methodology to enable comprehensive characterisation of infrarenal abdominal aortic aneurysm morphology in clinical and research applications</article-title>. <source>J Endovasc Ther</source>. <year>2012</year>;<volume>19</volume>(<issue>3</issue>):<fpage>400</fpage>–<lpage>414</lpage>.</citation>
</ref>
<ref id="bibr31-1538574412474497">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holt</surname>
<given-names>PJE</given-names>
</name>
<name>
<surname>Karthikesalingam</surname>
<given-names>A</given-names>
</name>
</person-group>, <article-title>Hofman D, et al. provider volume and the long-term outcome of elective abdominal aortic aneurysm repair</article-title>. <source>Br J Surg</source>. <year>2012</year>;<volume>99</volume>(<issue>5</issue>):<fpage>666</fpage>–<lpage>672</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>